DE1522361A1
(de)
|
1966-03-08 |
1969-07-24 |
Agfa Gevaert Ag |
Sensibilisierung lichtempfindlicher Polymerer
|
US3557142A
(en)
|
1968-02-20 |
1971-01-19 |
Sterling Drug Inc |
4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
|
DE1772867A1
(de)
|
1968-07-15 |
1971-06-16 |
Agfa Gevaert Ag |
Sensibilisierung von Schichten aus lichtvernetzbaren Polymeren
|
JPS5089367A
(es)
|
1973-12-14 |
1975-07-17 |
|
|
JPS57171986A
(en)
|
1981-04-14 |
1982-10-22 |
Taiho Yakuhin Kogyo Kk |
Heterocylic ring compound containing sulfur
|
DE3333450A1
(de)
|
1983-09-16 |
1985-04-11 |
Hoechst Ag, 6230 Frankfurt |
Trihalogenmethylgruppen enthaltende carbonylmethylenheterocyclen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt
|
US4978664A
(en)
|
1984-08-06 |
1990-12-18 |
Sterling Drug Inc. |
3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indole pharmaceutical compositions
|
US4885295A
(en)
|
1984-08-06 |
1989-12-05 |
Sterling Drug Inc. |
Method of use of 3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indoles
|
DE3533331A1
(de)
|
1985-09-18 |
1987-03-26 |
Heumann Ludwig & Co Gmbh |
Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
DE3807381A1
(de)
|
1988-03-07 |
1989-09-21 |
Hoechst Ag |
4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindung enthaelt
|
TW205041B
(es)
|
1989-08-07 |
1993-05-01 |
Fujisawa Pharmaceutical Co |
|
DE4021439A1
(de)
|
1989-12-14 |
1991-06-20 |
Bayer Ag |
2-iminopyridin-derivate
|
US6559186B1
(en)
|
1990-02-26 |
2003-05-06 |
Arc 1, Inc. |
Compositions and methods of treatment of sympathetically maintained pain
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
EP0639569A4
(en)
|
1991-03-11 |
1995-09-20 |
Nippon Soda Co |
NEW HETEROCYCLIC COMPOUND.
|
WO1993018031A1
(en)
|
1992-03-03 |
1993-09-16 |
Idemitsu Kosan Co., Ltd. |
Pyrazole derivative
|
EP0568096B1
(en)
|
1992-04-30 |
1998-07-29 |
Hodogaya Chemical Co., Ltd. |
Benzothiazole derivative and agricultural and horticultural fingicide composition containing the same
|
US5654322A
(en)
|
1992-08-11 |
1997-08-05 |
Wakunaga Seiyaku Kabushiki Kaisha |
Biphenylmethane derivatives and pharmaceuticals containing the same
|
JPH07507574A
(ja)
|
1993-04-05 |
1995-08-24 |
藤沢薬品工業株式会社 |
テストステロン5α−レダクターゼ阻害剤用インドール誘導体
|
US5395836A
(en)
|
1993-04-07 |
1995-03-07 |
Kyowa Hakko Kogyo Co., Ltd. |
8-tricycloalkyl xanthine derivatives
|
JPH06345736A
(ja)
|
1993-06-14 |
1994-12-20 |
Tokuyama Soda Co Ltd |
ウレタン化合物を製造する方法
|
MY115155A
(en)
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
WO1995031448A1
(en)
|
1994-05-17 |
1995-11-23 |
Dowelanco |
N-(5-isothiazolyl)amide pesticides
|
EP1221307B1
(en)
|
1994-07-08 |
2010-02-17 |
ev3 Inc. |
System for performing an intravascular procedure
|
FR2735774B1
(fr)
|
1995-06-21 |
1997-09-12 |
Sanofi Sa |
Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
|
ES2214546T3
(es)
|
1995-09-15 |
2004-09-16 |
PHARMACIA & UPJOHN COMPANY |
N-oxidos de aminoariloxazolidinona.
|
US20030220234A1
(en)
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
US6323214B1
(en)
|
1997-10-29 |
2001-11-27 |
Medco Research, Inc |
Allosteric adenosine receptor modulators
|
US6358992B1
(en)
|
1998-11-25 |
2002-03-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with indole derivatives
|
PT1171437E
(pt)
|
1999-04-20 |
2004-03-31 |
Syngenta Ltd |
Pesticidas derivados de indazole ou benzotriazole
|
DE19928033A1
(de)
|
1999-06-18 |
2000-12-21 |
Basf Ag |
Verwendung von cyclischen Enaminen als Lichtschutzmittel
|
FR2796643B1
(fr)
|
1999-07-22 |
2005-04-29 |
Sod Conseils Rech Applic |
Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
|
GB9918037D0
(en)
|
1999-07-30 |
1999-09-29 |
Biochemie Gmbh |
Organic compounds
|
ES2222919T3
(es)
|
1999-08-27 |
2005-02-16 |
Abbott Laboratories |
Compuestos sulfonilfenilpirazoles utiles como inhibidores de cox-2.
|
CA2384757A1
(en)
*
|
1999-09-14 |
2001-03-22 |
Shionogi & Co., Ltd. |
2-imino-1,3-thiazine derivatives
|
AU1095101A
(en)
|
1999-10-18 |
2001-04-30 |
University Of Connecticut, The |
Cannabimimetic indole derivatives
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
GB0002034D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
GB0006289D0
(en)
|
2000-03-15 |
2000-05-03 |
Smithkline Beecham Plc |
New use
|
GB0010437D0
(en)
|
2000-04-28 |
2000-06-14 |
Darwin Discovery Ltd |
Process
|
CN1944417A
(zh)
|
2000-06-30 |
2007-04-11 |
大日本住友制药株式会社 |
五元环化合物
|
US6369052B1
(en)
|
2000-08-07 |
2002-04-09 |
Georgetown University |
Combination of huperzine and nicotinic compounds as a neuroprotective agent
|
FR2816938B1
(fr)
|
2000-11-22 |
2003-01-03 |
Sanofi Synthelabo |
Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
|
ATE478670T1
(de)
|
2001-01-29 |
2010-09-15 |
Univ Connecticut |
Rezeptor-selektive cannabimimetische aminoalkylindole
|
US20030008807A1
(en)
|
2001-06-14 |
2003-01-09 |
The Regents Of The University Of California |
Novel signaling pathway for the production of inflammatory pain and neuropathy
|
US20040259912A1
(en)
|
2001-09-28 |
2004-12-23 |
Takahiro Matsumoto |
Benzine derivatives, process for preparing the same and use thereof
|
IL161661A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
US6727247B2
(en)
|
2001-12-10 |
2004-04-27 |
Hoffman-La Roche Inc. |
Substituted benzothiazole amide derivatives
|
ES2270080T3
(es)
|
2002-05-16 |
2007-04-01 |
Bayer Cropscience Gmbh |
Derivados de piridincarboxamida pesticidas.
|
JP3902523B2
(ja)
|
2002-08-05 |
2007-04-11 |
富士フイルム株式会社 |
光情報記録媒体および情報記録方法
|
US20040077617A1
(en)
|
2002-10-22 |
2004-04-22 |
Bennani Youssef L. |
Fused cycloalkyl amides and acids and their therapeutic applications
|
FR2847899B1
(fr)
|
2002-11-29 |
2006-04-28 |
Sanofi Synthelabo |
Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
|
US7390670B2
(en)
|
2003-02-20 |
2008-06-24 |
Lumigen, Inc. |
Signalling compounds and methods for detecting hydrogen peroxide
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
EP1640369A4
(en)
|
2003-06-27 |
2007-10-31 |
Dainippon Sumitomo Pharma Co |
THIAZOLIMINE COMPOUND AND OXAZOLIMINE COMPOUND
|
AU2004270394A1
(en)
|
2003-09-10 |
2005-03-17 |
Gpc Biotech Ag |
Heterobicyclic compounds as pharmaceutically active agents
|
RU2361868C2
(ru)
|
2003-12-08 |
2009-07-20 |
Ф.Хоффманн-Ля Рош Аг |
Новые производные тиазола
|
GB0402357D0
(en)
|
2004-02-03 |
2004-03-10 |
Glaxo Group Ltd |
Novel compounds
|
EP1737850B1
(en)
|
2004-04-19 |
2007-10-03 |
Symed Labs Limited |
A novel process for the preparation of linezolid and related compounds
|
SE0401345D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds: Pyridine as scaffold
|
SE0401342D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds
|
ES2325401T3
(es)
|
2004-07-20 |
2009-09-03 |
Symed Labs Limited |
Intermedios novedosos para linezolid y compuestos relacionados.
|
WO2006039164A2
(en)
|
2004-09-29 |
2006-04-13 |
Amr Technology, Inc. |
Novel cyclosporin analogues and their pharmaceutical uses
|
JPWO2006051704A1
(ja)
|
2004-11-15 |
2008-05-29 |
大正製薬株式会社 |
イミン化合物
|
EP1833824B1
(en)
|
2004-12-21 |
2016-08-03 |
AbbVie Inc. |
3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
|
FR2880023B1
(fr)
|
2004-12-23 |
2007-02-23 |
Sanofi Aventis Sa |
Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
|
US7759337B2
(en)
|
2005-03-03 |
2010-07-20 |
Amgen Inc. |
Phthalazine compounds and methods of use
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
US7674912B2
(en)
|
2005-04-25 |
2010-03-09 |
H. Lundbeck A/S |
Pro-drugs of N-thiazol-2-yl-benzamide derivatives
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
US7514068B2
(en)
|
2005-09-14 |
2009-04-07 |
Concert Pharmaceuticals Inc. |
Biphenyl-pyrazolecarboxamide compounds
|
EP1951678A1
(en)
|
2005-10-21 |
2008-08-06 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity
|
TW200804338A
(en)
|
2005-11-24 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
KR20090018685A
(ko)
|
2006-05-31 |
2009-02-20 |
아보트 러보러터리즈 |
칸나비노이드 수용체 리간드로서의 티아졸 화합물 및 이의 용도
|
US8841334B2
(en)
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
CA2647598A1
(en)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands and uses thereof
|
EP2035014A4
(en)
*
|
2006-06-01 |
2009-11-04 |
Sakura Properties Llc |
FUCOIDANE PREPARATIONS AND METHODS
|
CN101479262A
(zh)
|
2006-06-27 |
2009-07-08 |
艾博特公司 |
噻唑啉和唑啉衍生物及其应用方法
|
WO2008012105A1
(en)
*
|
2006-07-28 |
2008-01-31 |
Synthon B.V. |
Crystalline erlotinib
|
WO2008028093A1
(en)
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Compounds as cb2 cannabinoid receptor ligands
|
US7985768B2
(en)
|
2006-08-31 |
2011-07-26 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2008063781A2
(en)
|
2006-10-12 |
2008-05-29 |
Abbott Laboratories |
Chemical compounds as cannabinoid receptor ligands
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
US9763894B2
(en)
|
2006-12-05 |
2017-09-19 |
Virginia Commonwealth University |
Inflammation therapy
|
TW200831092A
(en)
|
2006-12-21 |
2008-08-01 |
Astrazeneca Ab |
Therapeutic agents
|
WO2008079687A1
(en)
|
2006-12-22 |
2008-07-03 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands and uses thereof
|
BRPI0807813A2
(pt)
|
2007-02-15 |
2014-08-05 |
Hoffmann La Roche |
2-amino-oxazolinas como ligantes de taar1
|
CA2681586A1
(en)
*
|
2007-03-28 |
2008-10-09 |
Abbott Laboratories |
1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8501794B2
(en)
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US7528131B2
(en)
|
2007-04-19 |
2009-05-05 |
Concert Pharmaceuticals Inc. |
Substituted morpholinyl compounds
|
CN101711253A
(zh)
|
2007-05-18 |
2010-05-19 |
雅培制药有限公司 |
用作大麻素受体配体的新化合物
|
US7531685B2
(en)
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
US8338623B2
(en)
|
2007-07-09 |
2012-12-25 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US20090131485A1
(en)
|
2007-09-10 |
2009-05-21 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
US20090118238A1
(en)
|
2007-09-17 |
2009-05-07 |
Protia, Llc |
Deuterium-enriched alendronate
|
US20090088416A1
(en)
|
2007-09-26 |
2009-04-02 |
Protia, Llc |
Deuterium-enriched lapaquistat
|
US20090082471A1
(en)
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched fingolimod
|
EP2209774A1
(en)
|
2007-10-02 |
2010-07-28 |
Concert Pharmaceuticals Inc. |
Pyrimidinedione derivatives
|
US9193713B2
(en)
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US20090105338A1
(en)
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
US8410124B2
(en)
|
2007-10-18 |
2013-04-02 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
US8044071B2
(en)
|
2007-10-18 |
2011-10-25 |
Abbott Laboratories |
Method for reducing side effects of CB2 receptor agonist therapy using a combination of a selective CB2 receptor agonist and a selective CB1 receptor antagonist
|
US20090131363A1
(en)
|
2007-10-26 |
2009-05-21 |
Harbeson Scott L |
Deuterated darunavir
|
MX2010005649A
(es)
*
|
2007-11-21 |
2010-08-18 |
Abbott Lab |
Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
|
JP2011513495A
(ja)
|
2008-03-11 |
2011-04-28 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての新規な化合物
|
EP2331516B1
(en)
|
2008-08-15 |
2013-03-13 |
Abbott Laboratories |
Imine derivatives as cannabinoid receptor ligands
|
US8846730B2
(en)
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
EP2428507B1
(en)
|
2008-09-16 |
2015-10-21 |
AbbVie Bahamas Ltd. |
Cannabinoid receptor ligands
|
JP2012508176A
(ja)
|
2008-11-04 |
2012-04-05 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての1,2−チアゾリル誘導体
|
PA8854001A1
(es)
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
WO2010111574A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
CA2756178A1
(en)
|
2009-03-27 |
2010-09-30 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
US8288428B2
(en)
|
2009-03-27 |
2012-10-16 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2011159785A1
(en)
|
2010-06-15 |
2011-12-22 |
Abbott Laboratories |
Novel compounds as cannabinoid receptor ligands
|